SCHEMBL13744508

SCHEMBL13744508

Nc1cc(Cl)cc(Cl)c1C(=O)NCc1ccc(I)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
TP53 P04637 3/20 0.41
MDM2 Q00987 3/20 0.41
EPHX2 P34913 1/20 0.41
HDAC1 Q13547 3/20 0.40
HDAC4 P56524 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
ALDH2 P05091 2/20 0.39
THRB P10828 2/20 0.39
HPGD P15428 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4214266 0.90 CYP2C19 (0.53) MEN1KMT2ACYP2C9CYP2C19CA1
SCHEMBL4223601 0.86 TP53 (0.50) KMT2ACYP2C19TP53MDM2HPGD
SCHEMBL13744662 0.86 TP53 (0.50) MEN1KMT2ACYP2C9CYP2C19CA1
SCHEMBL13744671 0.86 HPGD (0.53) MEN1KMT2ATP53THRBHPGD
SCHEMBL4223833 0.86 TP53 (0.54) MEN1KMT2ACYP2C19CA1CA2
SCHEMBL13744607 0.86 MEN1 (0.43) MEN1KMT2ACYP2C19TP53MDM2
SCHEMBL4211571 0.84 MEN1 (0.47) MEN1KMT2ATP53MDM2ALDH2
SCHEMBL13744864 0.84 HSD17B10 (0.54) KMT2ACA2HPGDALDH1A1
SCHEMBL4071141 0.83 AKR1B1 (0.49) MEN1KMT2ACA1CA2EPHX2
SCHEMBL13744520 0.83 TP53 (0.59) MEN1KMT2ACYP2C9CYP2C19TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203708-A1 NOVEL SUBSTITUTED-1-H-QUINAZOLINE-2,4-DIONE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2009-08-13 US disclosed
US-20090203708-A1 NOVEL SUBSTITUTED-1-H-QUINAZOLINE-2,4-DIONE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203708-A1 NOVEL SUBSTITUTED-1-H-QUINAZOLINE-2,4-DIONE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME HTR5A, HTR3B, HTR1A MEN1 3793/4885KMT2A 4058/4885CYP2C9 1068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.